ORVAR Autoantigen Discovery Platform
Accelerating the discovery of disease-specific autoantigens
Our proprietary ORVAR® autoantigen technology dramatically accelerates the discovery of the autoantigens within a specific disease—the Autoproteome®. This is a significant improvement over conventional methods, which would require screening every human protein, splice variant, neoantigen, or microbial antigen—a million or more possibilities—to reveal the total repertoire of autoantigens for that disease.